Skip to content

Clinical efficacy study of Ruyi Zhenbao tablets combined with electroacupuncture in the treatment of lumbar spinal stenosis

Clinical efficacy study of Ruyi Zhenbao tablets combined with electroacupuncture in the treatment of lumbar spinal stenosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002607
Enrollment
Unknown
Registered
2025-12-30
Start date
2025-04-30
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar spinal stenosis

Interventions

test group:Ruyi Jumbo Tablet with Electroacupuncture
control subjects:Electroacupuncture

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Meet the western medical diagnostic criteria of LSS; 2) 40 years old =age =80 years old; 3) NRS =4 points before enrollment; 4) Those who voluntarily accept and complete the treatment as a subject and sign the informed consent; 5) If the patient is undergoing or has recently undergone other therapeutic regimens the patient must undergo a washout period of at least 1 week.

Exclusion criteria

Exclusion criteria: 1) patients with clear surgical indications such as lumbar spondylolisthesis segmental muscular dystrophy bowel or bladder disorders; 2) the existence of intermittent claudication of spinal cord origin or vascular intermittent claudication; 3) the existence of spinal infections tumors tuberculosis traumatic injury and fracture ankylosing spondylitis etc.; 4) a combination of serious cardiovascular renal hepatic gastrointestinal tract ulcer hematopoietic system and other diseases; 5) allergic or known allergic to the drugs and their ingredients used in this trial; 6) not suitable for participation in clinical research in special groups (pregnant or six months to prepare for pregnancy lactating women blind deaf mute mental or spiritual disorders). People with allergies or known hypersensitivity to the drugs used in this trial and their components; 6) Special groups of people who are not suitable to participate in the clinical study (pregnant women or women who are going to be pregnant within half a year lactating women blind deaf mute mentally or psychologically impaired etc.)

Design outcomes

Primary

MeasureTime frame
Oswestry disability index;

Secondary

MeasureTime frame
numerical rating scale;10-meter pace;Degree of intermittent claudication;Zurich Claudication Questionnaire,ZCQ;

Countries

China

Contacts

Public ContactZhaoYongfang

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

1903529907@qq.com13501819578

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026